MNMD

The MindMed Psychedelic Revolution Will Take Years to Come to Fruition

Psychedelics-Focused MindMed Joins FTSE Russell 3000 Index, 'A True Honor'

MindMed Can Play a Big Role in the Growing Mental Wellness Industry

Why This MindMed Analyst Is Bullish: 'One Of The Most Diverse Pipelines In Psychedelics'

MindMed Included in FTSE Russell 3000® Index

MindMed Appoints MGH Psychiatrist-in-Chief Dr. Maurizio Fava to Scientific Advisory Board